Tetanus Toxoid Overview Categories 19 Immunologicals19.3 Vaccines19.3.2 Vaccines for specific groups of individuals Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Pegloticase Manufacturers of Pegloticase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Pegloticase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 40 IU40 (40)As recommended.IM2 Inj. at an interval of 4 weeks. 3rd Inj. after 3-12 months, 4th inj. after 1 year and then after 5 years. Booster Dose, Every 10-Years Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Pegloticase is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Pegloticase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Pegloticase Back to top Manufacturers of Tetanus Toxoid in Pakistan Amson Aventis GENE-TECH LABS GSK Hakimsons Pliva Back to top Previous Drug Generic - Next Drug Generic
Tetanus Toxoid Overview Categories 19 Immunologicals19.3 Vaccines19.3.2 Vaccines for specific groups of individuals Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Pegloticase Manufacturers of Pegloticase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Pegloticase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 40 IU40 (40)As recommended.IM2 Inj. at an interval of 4 weeks. 3rd Inj. after 3-12 months, 4th inj. after 1 year and then after 5 years. Booster Dose, Every 10-Years Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Pegloticase is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Pegloticase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Pegloticase Back to top Manufacturers of Tetanus Toxoid in Pakistan Amson Aventis GENE-TECH LABS GSK Hakimsons Pliva Back to top Previous Drug Generic - Next Drug Generic